Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

Completed No Results Available Drug: Amlodipine+Rosuvastatin|Drug: GSK3074477 FDC ‐ 1|Drug: GSK3074477 FDC ‐ 2 Both Adult Phase 1 24 Interventional Allocation: Randomized|Endpoint Classification: Bio‐availability Study|Intervention Model: Crossover Assignment|Primary Purpose: Treatment|Masking: Open Label Plasma pharmacokinetics (PK) parameters of amlodipine and rosuvastatin following single dose administration|Additional PK parameters of amlodipine and rosuvastatin following single dose administration|Safety as assessed by adverse events|Safety as assessed by vital signs|Safety as assessed by clinical laboratory safety data|Safety as assessed by Electrocardiogram (ECG) parameters